Vice President, Head Clinical Pharmacology Sciences
Gilead Sciences
Foster City, California, United States
Dr. Sandhya Girish is the Vice President of Clinical Pharmacology Sciences at Gilead Sciences, Inc. In her role, Dr. Girish provides strategic and scientific leadership for clinical pharmacology, pharmacometrics and bioanalytical strategies for NMEs spanning both early and late stages of development. Her department is actively involved in pediatric and adult R&D programs across virology, oncology, and inflammation and is responsible for integrated clinical pharmacology, and Modeling & Simulation strategies, including applying model informed drug development (MIDD) approaches where appropriate. Sandhya is passionate about combining insights from clinical trials with data from virtual clinical trials, pharmacodynamics, RWD/RWE, AI/ML, pharmacogenomics personalize drug development.
Dr. Girish has over two decades of experience in the discovery and development at start-up (Genesoft), CRO (Stanford Research Institute- SRI International) and big pharma companies (Novartis and Roche/Genentech). Dr. Girish has published extensively and has numerous publications, book chapters, review papers and posters to her credit. Dr. Girish has organized scientific sessions and is an invited speaker in several international meetings. With support from her team Dr. Girish has successfully led and supported numerous submissions.
In addition, she served as an IQ Board Member and was the Vice Chair and Chair of the Clinical Pharmacology Leadership Group (CPLG) of the International Consortium for Innovation & Quality (IQ) in Pharmaceutical Development (2017-2020). Sandhya was the recipient of a Rising Star Award in 2020 from the Healthcare Businesswomen’s Association and a Career Champion Award at Gilead in 2022. She is passionate about mentoring young career scientists and is passionate to boost women's leadership in science.
Dr. Girish received her doctorate in biomedical sciences with specialization in pharmacokinetics and drug metabolism from Northeastern University, Boston MA. She also has a Masters degree (M.Pharm) in pharmaceutical sciences and Bachelors in Pharmacy (BPharm) degrees from Hamdard College of Pharmacy, New Delhi, India.
Disclosure information not submitted.
Pharmacometrics to accelerate first registration
Saturday, October 18, 2025
9:15 AM - 9:30 AM MDT